These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1696292

  • 1. Effects of mianserin on negative symptoms in schizophrenia.
    Mizuki Y, Kajimura N, Imai T, Suetsugi M, Kai S, Kaneyuki H, Yamada M.
    Int Clin Psychopharmacol; 1990 Apr; 5(2):83-95. PubMed ID: 1696292
    [Abstract] [Full Text] [Related]

  • 2. Effects of mianserin in chronic schizophrenia.
    Mizuki Y, Kajimura N, Kai S, Suetsugi M, Ushijima I, Yamada M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):517-28. PubMed ID: 1641495
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia.
    Kuniyoshi M, Nakamura J, Miura C, Inanaga K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):339-46. PubMed ID: 7516085
    [Abstract] [Full Text] [Related]

  • 4. Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.
    Hatzimanolis J, Lykouras L, Markianos M, Oulis P.
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1077-85. PubMed ID: 9829289
    [Abstract] [Full Text] [Related]

  • 5. Mianserin or placebo as adjuncts to typical antipsychotics in resistant schizophrenia.
    Shiloh R, Zemishlany Z, Aizenberg D, Valevski A, Bodinger L, Munitz H, Weizman A.
    Int Clin Psychopharmacol; 2002 Mar; 17(2):59-64. PubMed ID: 11890187
    [Abstract] [Full Text] [Related]

  • 6. Associations between five-factor model of the Positive and Negative Syndrome Scale and plasma levels of monoamine metabolite in patients with schizophrenia.
    Watanabe K, Miura I, Kanno-Nozaki K, Horikoshi S, Mashiko H, Niwa S, Yabe H.
    Psychiatry Res; 2015 Dec 15; 230(2):419-23. PubMed ID: 26416588
    [Abstract] [Full Text] [Related]

  • 7. Biogenic amine metabolites in plasma of drug-naive schizophrenic patients: associations with symptomatology.
    Markianos M, Botsis A, Arvanitis Y.
    Biol Psychiatry; 1992 Aug 01; 32(3):288-92. PubMed ID: 1384728
    [Abstract] [Full Text] [Related]

  • 8. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H, Yoshimura R, Katsuki A, Atake K, Igata R, Konishi Y, Nakamura J.
    World J Biol Psychiatry; 2017 Aug 01; 18(5):401-408. PubMed ID: 27409727
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium.
    Nakamura J, Uchimura N, Yamada S, Nakazawa Y.
    Int Clin Psychopharmacol; 1997 May 01; 12(3):147-52. PubMed ID: 9248871
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA.
    J Clin Psychopharmacol; 2010 Oct 01; 30(5):496-503. PubMed ID: 20814316
    [Abstract] [Full Text] [Related]

  • 15. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
    Mazure CM, Nelson JC, Jatlow PI, Bowers MB.
    Biol Psychiatry; 1991 Sep 01; 30(5):475-82. PubMed ID: 1932395
    [Abstract] [Full Text] [Related]

  • 16. Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline.
    Mendlewicz J, Pinder RM, Stulemeijer SM, Van Dorth R.
    J Affect Disord; 1982 Sep 01; 4(3):219-26. PubMed ID: 6182175
    [Abstract] [Full Text] [Related]

  • 17. Effects of raclopride treatment on plasma and CSF HVA: relationships with clinical improvement in male schizophrenics.
    Csernansky JG, Newcomer JW, Jackson K, Lombrozo L, Faull KF, Zipursky R, Pfefferbaum A, Faustman WO.
    Psychopharmacology (Berl); 1994 Nov 01; 116(3):291-6. PubMed ID: 7534423
    [Abstract] [Full Text] [Related]

  • 18. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D, Levy C, Azorin JM, Bruno M, Valli M.
    Encephale; 1992 Nov 01; 18(6):611-6. PubMed ID: 1285270
    [Abstract] [Full Text] [Related]

  • 19. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S, Iwamoto N, Arai H.
    Biol Psychiatry; 1997 Apr 15; 41(8):857-64. PubMed ID: 9099412
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.